SavedAdd your journal

Journals / Psychiatry and behavioral sciences (Online) / 2019 / Cilt: 9 - Sayı: 2

Risperidone-Induced Alopecia in a Child with Autism Spectrum Disorder (ASD)

Hamza AYAYDIN
Sermin BİLGEN ULGAR
Pages
57–59
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To the best of our knowledge, this is the first report of alopecia induced by risperidone during treatment of self-injurious behaviours in a child female patient with ASD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Autism spectrum disorder (ASD) is a complex heterogeneous neurodevelopmental disorder.
📊
Key Findings & Data:Risperidone appears to be effective in associated behavioral problems with ASD.
💡
Conclusion & Impact:To the best of our knowledge, this is the first report of alopecia induced by risperidone during treatment of self-injurious behaviours in a child female patient with ASD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Autism spectrum disorder (ASD) is a complex heterogeneous neurodevelopmental disorder. Risperidone appears to be effective in associated behavioral problems with ASD. Alopecia can be drug-induced and has been associated with several psychotropic drugs. Antipsychotics would seem to act by triggering a premature telogen or resting phase, resulting in hair loss. Here, we report a female patient ASD developing alopecia following risperidone use. To the best of our knowledge, this is the first report of alopecia induced by risperidone during treatment of self-injurious behaviours in a child female patient with ASD.

🔖

Cite This Article

AYAYDIN, H., ULGAR, S. B. (2019). Risperidone-Induced Alopecia in a Child with Autism Spectrum Disorder (ASD). Psychiatry and behavioral sciences (Online), Cilt: 9 - Sayı: 2, 57–59. https://ajindex.com/articles/302844

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, et al. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. J Am Acad Child Adolesc Psychiatry 2003;42(12):1443-50
  2. Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009;48(11):1110-9
  3. Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin 2007;25(2):223-31
  4. Karabulut S, Cakir S. A case with alopecia related to risperidone use. Anadolu Psikiyatri Derg 2016;17(Suppl. 3):S55-S7
  5. McLean RM, Harrison-Woolrych M. Alopecia associated with quetiapine. Int Clin Psychopharmacol 2007;22(2):117-9
  6. Kuloglu M, Korkmaz S, Kilic N, Saglam S, Gurok MG, Atmaca M. Olanzapine induced hair loss: a case report. Bulletin of Clinical Psychopharmacology 2012;22(4):362-6
  7. Savasir I, Sezgin N, Erol N. Ankara Gelisim Tarama El Kitabi. Ankara: Türk Psikologlar Dernegi. 1994. (Turkish
  8. Yilmaz-Irmak T, Sutcu ST, Aydin A, Sorias O. An investigation of validity and reliability of Autism Behavior Checklist (ABC). Turkish Journal of Child and Adolescent Mental Health 2007:14(1);13-23
  9. Sucuoglu B, Oktem F, Akkok F, Gokler B. A study about childhood autism scales. 3P Dergisi 1996:4(2);116-21. [Turkish] 10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association Publishing, 2013: 50-9
  10. Kose S, Akin E, Cetin M. Adverse drug reactions and causality: the Turkish version of Naranjo Adverse Drug Reactions Probability Scale. Psychiatry and Clinical Psychopharmacology 2017;27(2):205-6
  11. Warnock JK, Morris DW. Adverse cutaneous reactions to antipsychotics. Am J Clin Dermatol 2002;3(9):629-36
  12. Mercke Y, Sheng H, Khan T, Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000;12(1):35-42
  13. Kubota T, Ishikura T, Jibiki I. Alopecia areata associated with haloperidol. Jpn J Psychiatry Neurol 1994;48(3):579-81
  14. Demir AC, Ozcan O. Aripiprazole-related alopesia: A case report. Journal of Turgut Ozal Medical Center 2017;24(4):500-1
  15. Yazici KU, Percinel I. Quetiapine induced hair loss in an adolescent case. Anadolu Psikiyatri Derg 2015;16(2):143-5.